Literature DB >> 12166095

[The Japanese version of RBANS (Repeatable Battery for the Assessment of Neuropsychological Status)].

Tetsumori Yamashima1, Manami Yoshida, Kazuhiko Kumahashi, Mie Matsui, Yoshifumi Koshino, Masato Higashima, Tatsuya Nagasawa, Akira Ueki, Mieko Ohtsuka, Shozo Aoki, Shinya Imuro, Norio Mori, Norichika Takei, Ryouichi Hoshino, Yoshio Minabe, Yoshio Nanba, Mayumi Nanba, Jun-ichi Kira, Yasumasa Ohyagi, Joh Haraoka, Jiro Akimoto, Nobuyoshi Miura, Shingo Kimura, Masaaki Matsushita.   

Abstract

In Japan, neuropsychological assessment of dementing illnesses has been done mainly using Mini-Mental State Examination (MMSE) and a revised version of Hasegawa Dementia Scale (HDS-R). However, because of a lack of appropriately designed test domains, early detection of senile dementia and/or cognitive impairment is hardly possible, even if using these batteries. This paper is to introduce a Japanese Version of RBANS (Repeatable Battery for the Assessment of Neuropsychological Status) which was originally developed by Randolph and revised by us. The entire battery of Japanese Version RBANS took less than 30 minutes to administer, and yielded scaled scores for five cognitive domains such as immediate memory, visuospatial/constructional ability, language, attention, and delayed memory. On RBANS, abnormal cognitive decline in the older adult was much easily detected, being compared to MMSE and HDS-R: 52 normal volunteer subjects ranging from 24 to 80 years old showed a significant (p < 0.05 on t test) impairment of delayed and immediate memories due to ageing. The aged (60-79) subjects with average scores of MMSE and HDS-R being over 25, significantly showed impairment of both immediate memory (list and story learnings) and delayed memory (list, story and figure recalls). The present data suggest that the Japanese Version RBANS is useful for both detecting and characterizing early dementia, and should be widely utilized for a neuropsychological screening battery in the clinical practice throughout Japan.

Entities:  

Mesh:

Year:  2002        PMID: 12166095

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  9 in total

1.  Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study.

Authors:  Hiroyoshi Takeuchi; Takefumi Suzuki; Gary Remington; Robert R Bies; Takayuki Abe; Ariel Graff-Guerrero; Koichiro Watanabe; Masaru Mimura; Hiroyuki Uchida
Journal:  Schizophr Bull       Date:  2013-07-01       Impact factor: 9.306

2.  Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.

Authors:  Kevin Duff; Christopher Randolph; Adam L Boxer
Journal:  Clin Neuropsychol       Date:  2019-09-27       Impact factor: 3.535

3.  Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors:  Kevin Duff; Dana McDermott; Dan Luong; Christopher Randolph; Adam L Boxer
Journal:  J Clin Exp Neuropsychol       Date:  2019-02-04       Impact factor: 2.475

4.  The value of 4-month neurocognitive function as an endpoint in brain metastases trials.

Authors:  Shunsuke Onodera; Hidefumi Aoyama; Khin Khin Tha; Naoki Hashimoto; Atsuhito Toyomaki; Satoshi Terae; Hiroki Shirato
Journal:  J Neurooncol       Date:  2014-07-19       Impact factor: 4.130

5.  Effects of a Cooking Program Based on Brain-activating Rehabilitation for Elderly Residents with Dementia in a Roken Facility: A Randomized Controlled Trial.

Authors:  Tatsuhiko Murai; Haruyasu Yamaguchi
Journal:  Prog Rehabil Med       Date:  2017-03-07

6.  Supplementation With Whey Peptide Rich in β-Lactolin Improves Cognitive Performance in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Masahiro Kita; Keiko Kobayashi; Kuniaki Obara; Takashi Koikeda; Satoshi Umeda; Yasuhisa Ano
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

7.  Impact of bilateral subthalamic stimulation on motor/cognitive functions in Parkinson's disease.

Authors:  Takashi Asahi; Naomi Nakamichi; Akiko Takaiwa; Daina Kashiwazaki; Masaki Koh; Nobuhiro Dougu; Shutaro Takashima; Kortaro Tanaka; Satoshi Kuroda
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-05-29       Impact factor: 1.742

Review 8.  Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes.

Authors:  Yoshie Omachi; Tomiki Sumiyoshi
Journal:  Front Psychiatry       Date:  2018-09-20       Impact factor: 4.157

9.  The Korean Repeatable Battery for the Assessment of Neuropsychological Status-Update : Psychiatric and Neurosurgery Patient Sample Validity.

Authors:  Jong-Ok Park; Bon-Hoon Koo; Ji-Yean Kim; Dai-Seg Bai; Mun-Seon Chang; Oh-Lyong Kim
Journal:  J Korean Neurosurg Soc       Date:  2020-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.